Abbott Laboratories’ sales of COVID-19 tests fell by a whopping 89% during the second quarter of this year compared with the same time last year — a drop that comes as the world attempts to move on from the pandemic.
North suburban-based Abbott makes the once popular rapid, at-home COVID-19 test BinaxNOW. From April through June, Abbott sold $263 million worth of COVID-19 tests, compared with $2.3 billion during the same time last year.
Abbott leaders said during an earnings call Thursday morning that the decrease was expected and the overall business is otherwise strong.
